Bay Harbor Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-150
Closed -$4K 368
2019
Q3
$4K Hold
150
﹤0.01% 274
2019
Q2
$4K Hold
150
﹤0.01% 274
2019
Q1
$4K Hold
150
﹤0.01% 314
2018
Q4
$3K Buy
+150
New +$3.33K ﹤0.01% 305

Other funds holding NVO

Bay Harbor Wealth Management's NVO Position: Q4 2019 in Review

Bay Harbor Wealth Management sold out of Novo Nordisk (NVO) in Q4 2019, closing a stake of 150 shares — an estimated $4K sold.

Bay Harbor Wealth Management first reported a position in NVO in Q4 2018 and held it in 4 quarters. The position peaked at $4K in Q3 2019. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

  • Bay Harbor Wealth Management reported no remaining Novo Nordisk position as of Q4 2019 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 150 Novo Nordisk shares in Q4 2019, an estimated $4K.
  • Bay Harbor Wealth Management first reported a position in Novo Nordisk in Q4 2018 and held it in 4 quarters.
  • Bay Harbor Wealth Management's Novo Nordisk position peaked at $4K in Q3 2019.
  • 640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Bay Harbor Wealth Management's 13F filing for Q4 2019, filed 27 Jan 2020.